PIM
Platinum Investment Management Portfolio holdings
AUM
$1.5B
This Quarter Return
-6.35%
1 Year Return
+16.62%
3 Year Return
+100.57%
5 Year Return
+187.54%
10 Year Return
+422.09%
AUM
$3.55B
AUM Growth
+$3.55B
(-18%)
Cap. Flow
-$1.34B
Cap. Flow
% of AUM
-37.62%
Top 10 Holdings %
Top 10 Hldgs %
58.31%
Holding
161
New
16
Increased
39
Reduced
56
Closed
15
Top Buys
| 1 |
Alibaba
BABA
|
$103M |
| 2 |
Trip.com Group
TCOM
|
$83M |
| 3 |
IDEAYA Biosciences
IDYA
|
$23.5M |
| 4 |
ICVX
Icosavax, Inc. Common Stock
ICVX
|
$23.3M |
| 5 |
BTRS
BTRS Holdings Inc. Class 1 Common Stock
BTRS
|
$21.6M |
Top Sells
| 1 |
Ally Financial
ALLY
|
$174M |
| 2 |
Louisiana-Pacific
LPX
|
$122M |
| 3 |
Wabtec
WAB
|
$106M |
| 4 |
American Eagle Outfitters
AEO
|
$102M |
| 5 |
Yum China
YUMC
|
$49.1M |
Sector Composition
| 1 | Technology | 23.17% |
| 2 | Industrials | 21.06% |
| 3 | Consumer Discretionary | 20.58% |
| 4 | Healthcare | 13.96% |
| 5 | Materials | 10.45% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
76
Wave Life Sciences
WVE
$1.27B
| $3.8M | 0.11% |
776,121
+569,737
| +276% | +$2.79M |
|
77
Alpha Teknova
TKNO
$227M
| $3.73M | 0.11% |
150,000
| – | – |
|
|
MDLA
78
DELISTED
Medallia, Inc.
MDLA
| $3.7M | 0.1% |
109,307
-796,677
| -88% | -$27M |
|
79
Werewolf Therapeutics
HOWL
$62.6M
| $3.66M | 0.1% |
213,381
+6,466
| +3% | +$111K |
|
|
INBX
80
DELISTED
Inhibrx, Inc. Common Stock
INBX
| $3.45M | 0.1% |
103,583
-51,818
| -33% | -$1.73M |
|
81
Absci
ABSI
$356M
| $3.34M | 0.09% |
+287,560
| New | +$3.34M |
|
82
908 Devices
MASS
$199M
| $3.28M | 0.09% |
100,961
+51,801
| +105% | +$1.68M |
|
83
Analog Devices
ADI
$120B
| $3.04M | 0.09% |
18,145
-12,139
| -40% | -$2.03M |
|
84
PayPal
PYPL
$66.5B
| $3M | 0.08% |
11,543
-1,056
| -8% | -$275K |
|
|
X
85
DELISTED
US Steel
X
| $3M | 0.08% |
136,600
+64,664
| +90% | +$1.42M |
|
|
BPMC
86
DELISTED
Blueprint Medicines
BPMC
| $2.79M | 0.08% |
27,121
| – | – |
|
87
Adaptive Biotechnologies
ADPT
$1.96B
| $2.78M | 0.08% |
81,894
+23,004
| +39% | +$782K |
|
88
Ovid Therapeutics
OVID
$94.6M
| $2.58M | 0.07% |
766,901
+370,031
| +93% | +$1.24M |
|
89
Carvana
CVNA
$50B
| $2.51M | 0.07% |
8,316
-16,454
| -66% | -$4.96M |
|
|
BCEL
90
DELISTED
Atreca, Inc. Class A Common Stock
BCEL
| $2.48M | 0.07% |
398,541
+81,524
| +26% | +$508K |
|
|
ORTX
91
DELISTED
Orchard Therapeutics plc American Depositary Shares
ORTX
| $2.48M | 0.07% |
107,832
+32,621
| +43% | +$750K |
|
92
Alkermes
ALKS
$4.95B
| $2.47M | 0.07% |
80,185
-101,901
| -56% | -$3.14M |
|
|
XLRN
93
DELISTED
Acceleron Pharma Inc.
XLRN
| $2.39M | 0.07% |
13,872
| – | – |
|
94
Dianthus Therapeutics
DNTH
$781M
| $2.34M | 0.07% |
20,044
| – | – |
|
95
Avidity Biosciences
RNA
$6.12B
| $2.33M | 0.07% |
94,496
+79,496
| +530% | +$1.96M |
|
96
Oracle
ORCL
$628B
| $2.2M | 0.06% |
25,213
-571
| -2% | -$49.8K |
|
97
Full Truck Alliance
YMM
$13.8B
| $2.18M | 0.06% |
+141,924
| New | +$2.18M |
|
98
Arcus Biosciences
RCUS
$1.24B
| $2.15M | 0.06% |
61,780
-13,510
| -18% | -$471K |
|
99
BioNTech
BNTX
$24.1B
| $2.05M | 0.06% |
7,492
-54,567
| -88% | -$14.9M |
|
100
Sangamo Therapeutics
SGMO
$161M
| $1.97M | 0.06% |
218,336
| – | – |
|